The global vitamin K market is slated to depict substantial growth over the coming years, due to an increase in the number of coagulation disorders across various regions. These disorders distort blood clotting mechanism that leads to various chronic conditions comprising thrombosis and hemorrhage.

The market is further propelled by the prevalence of improved health outcomes in COVID-19 patients having a better status of vitamin K. A related research published in the journal Preprints in April 2020 suggests the link between low vitamin K levels and the accelerated breakdown of tissue fibers, comprising elastin, which is associated with pulmonary disease.

Request for a sample copy of this report @ https://www.decresearch.com/request-sample/detail/1481  

Such studies are expected to bolster the demand for vitamin K supplements through the forthcoming years. According to the latest research by Global Market Insights, Inc., the global vitamin K market share is estimated to surpass USD 1 billion by 2025.

Some major trends boosting vitamin K industry landscape are as follows:

Rising product deployment for the treatment of VKDB

Vitamin K deficiency bleeding is mainly observed in young infants and occurs due to the lesser concentration of vitamin K in plasma. The vit-K deficiency bleeding segment in the vitamin K industry is likely to exhibit nearly 8.5 percent growth over the assessment span.

The deficiency leads to an increased risk of the development of severe hemorrhages in new-borns. Major vitamin K benefits comprise effective protection from the late and classic form of vitamin K deficiency bleeding and therefore, play a key role in curing infants, boosting segment growth through the forecasted period.

Increasing demand for vitamin K in Latin America

Latin America is characterized by an increase in government policies and programs for the eradication of health-associated issues. The Latin America vitamin K industry is estimated to record over 9 percent growth through 2025.

The region is experiencing a gradual improvement in healthcare infrastructure and numerous initiatives are in progress for the purpose of creating awareness regarding the adverse impacts of micronutrient deficiency. These factors are expected to propel business expansion in the region.

Request for customization @ https://www.decresearch.com/roc/1481

Escalating usage of vitamin K1

The vitamin K1 segment had a valuation of nearly USD 400 million in 2018 and is estimated to record commendable growth through 2025. This is because the deficiency of vitamin K1 creates an adverse impact on the development of teeth and bones as it plays a vital role in the incorporation of calcium phosphate into bones.

Furthermore, the latest available phytonadione provides increased absorption of vitamin K1 tablets in comparison with the previous ones. The significance of vitamin K1 medications in the treatment of numerous diseases will augment vitamin K market size over the coming years.

Soaring popularity of parenteral formulations

Parenteral formulations are used for avoiding metabolic pathways that are instrumental for the degradation of most of the drugs. The parenteral segment was valued at over USD 160 million in 2018 and will record remarkable growth through the assessment span.

Enhanced bioavailability of the parenteral formulations allows quick delivery at specific site of action with the required amount of dosage.

In a nutshell, shifting lifestyle patterns and the consumption of unhealthy foods leading to several chronic conditions will spur vitamin K market growth through the projected period.

Partial Chapter of the Table of Content

Chapter 2. Executive Summary

2.1. Vitamin K industry 360⁰ synopsis, 2014 - 2025

2.1.1. Business trends

2.1.2. Type trends

2.1.3. Application trends

2.1.4. Route of administration trends

2.1.5. Regional trends

Chapter 3. Vitamin K Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2014 – 2025

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.1.1. Growing number of clinical research activities related to development of vitamin K products in North America and Asia Pacific

3.3.1.2. Rising number of coagulation disorders globally

3.3.1.3. Lifestyle and dietary changes leading to deficiency of vitamin K in developed as well as developing countries

3.3.1.4. Growing prevalence of chronic diseases

3.3.1.5. Increasing awareness regarding availability of commercially viable vitamin K products in Asia Pacific

3.3.2. Industry pitfalls & challenges

3.3.2.1. Side effects associated with vitamin K dosage

3.4. Growth potential analysis

3.4.1. By type

3.4.2. By application

3.4.3. By route of administration

3.5. Porter’s analysis

3.6. Competitive landscape, 2018

3.6.1. Strategy dashboard

3.7. PESTEL analysis

Browse complete Table of Contents (ToC) of this research report @ https://www.decresearch.com/toc/detail/vitamin-k-market